BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) [Yahoo! Finance]
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
BiomX Announces the Appointment of Susan Blum to its Board of Directors
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure